UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 05/2020, Volume 75, Issue 5, pp. 1324 - 1331
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2013, Volume 57, Issue 6, pp. 903 - 914
Pregnancy | HIV/AIDS | Antiretrovirals | Disease transmission | HIV | Infants | Viral load | Carts | Cesarean section | HIV 1 | Assisted reproductive techniques | toxicity | zidovudine | mother-to-child HIV transmission | intrapartum prophylaxis | pregnancy | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Antiviral agents | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV Infections - prevention & control | Prospective Studies | Pregnancy Complications, Infectious - epidemiology | HIV Infections - epidemiology | Humans | Risk Factors | Male | Antibiotic Prophylaxis | Chi-Square Distribution | Viral Load | Pregnancy Complications, Infectious - drug therapy | Pregnancy Complications, Infectious - prevention & control | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | HIV Infections - transmission | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - statistics & numerical data | Infectious Disease Transmission, Vertical - prevention & control | Infant, Newborn | Prevention | Dosage and administration | HIV (Viruses) | Drug therapy | Zidovudine | Health aspects | Antiretroviral drugs | Maternal & child health | Human immunodeficiency virus--HIV | Virology | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 7/2015, Volume 61, Issue 2, pp. 270 - 280
HIV/AIDS | PMTCT | zidovudine | heart function | randomized trial | congenital heart defects | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Infections - prevention & control | Heart Septal Defects, Ventricular - epidemiology | Lamivudine - administration & dosage | Pregnancy Complications, Infectious - virology | Follow-Up Studies | Heart Defects, Congenital - etiology | Humans | Infant | Male | Pregnancy Trimester, First | Zidovudine - administration & dosage | Lamivudine - adverse effects | Young Adult | Uterus | Heart Septal Defects, Ventricular - etiology | Heart Septal Defects, Ventricular - diagnosis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | France | Echocardiography | Zidovudine - adverse effects | Anti-HIV Agents - adverse effects | Pregnancy | Pregnancy Complications, Infectious - drug therapy | Sex Factors | Heart Defects, Congenital - epidemiology | HIV Infections - drug therapy | Heart Defects, Congenital - diagnosis | Zidovudine - therapeutic use | Infectious Disease Transmission, Vertical - prevention & control | Drug Combinations | Prevention | Usage | Maternal health services | Disease transmission | Clinical trials | Dosage and administration | Management | Drug therapy | HIV infection | Zidovudine | Risk factors | Heart | Confidence intervals | Antiretroviral drugs | Congenital diseases | Prenatal development | Index Medicus
Journal Article
AIDS (London), ISSN 0269-9370, 10/2020, Volume 35, Issue 2, pp. 219 - 226
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 03/2019, Volume 74, Issue 3, pp. 739 - 745
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 10/2019, Volume 69, Issue 9, pp. 1498 - 1505
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 02/2019, Volume 68, Issue 4, pp. 597 - 606
Lipids | HIV | Protease inhibitors | Cholesterol | Dolutegravir | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | HIV Protease Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Drug Substitution - methods | HIV Protease Inhibitors - administration & dosage | HIV Integrase Inhibitors - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | HIV Integrase Inhibitors - adverse effects | Heterocyclic Compounds, 3-Ring - administration & dosage | Heterocyclic Compounds, 3-Ring - adverse effects | Lipids - blood | Adolescent | Aged, 80 and over | Adult | Female | HIV Infections - drug therapy | Aged | Antiretroviral Therapy, Highly Active - methods | Index Medicus
Journal Article
The Journal of pediatrics, ISSN 0022-3476, 11/2018, Volume 202, pp. 311 - 314.e2
newborn | TREC | HIV | T cell | pregnancy | lymphocyte | Life Sciences & Biomedicine | Pediatrics | Science & Technology | Measurement | Infants (Newborn) | Nucleosides | HIV testing | DNA polymerases | T cells | HIV (Viruses) | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Santé publique et épidémiologie
Journal Article
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 12, pp. 3307 - 3310
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prospective Studies | HIV Infections - virology | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Drug Interactions | HIV-1 - isolation & purification | Anti-HIV Agents - pharmacokinetics | Adult | Female | HIV Infections - drug therapy | Aged | Heterocyclic Compounds, 3-Ring - pharmacokinetics | Nevirapine - administration & dosage | Prescription drugs | Kinetics | Metabolism | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Antiviral therapy, ISSN 1359-6535, 01/2014, Volume 19, Issue 1, pp. 117 - 123
Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Science & Technology | Virology | HIV-1 | Follow-Up Studies | HIV Infections - virology | Humans | Middle Aged | Protease Inhibitors | Risk Factors | Pyrrolidinones - therapeutic use | Male | Nevirapine - therapeutic use | Treatment Outcome | CD4 Lymphocyte Count | Viral Load | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Female | HIV Infections - drug therapy | Retrospective Studies | Reverse Transcriptase Inhibitors | Drug Substitution | Raltegravir Potassium | Drug Combinations
Journal Article